Injective (INJ) is a layer-one blockchain designed to support the development of decentralized finance (DeFi) applications, including decentralized spot and derivatives exchanges, prediction markets, and lending protocols. It offers foundational financial infrastructure like a fully decentralized on-chain order book, aiming to support various financial markets such as spot, perpetual, futures, and options—all executed fully on-chain. Injective is compatible with Ethereum, IBC-enabled blockchains, and non-EVM chains like Solana. Built using the Cosmos SDK, it employs a Tendermint-based Proof-of-Stake consensus mechanism, which strives to deliver instant transaction finality and high performance.

Injective utilizes a Tendermint-based Proof-of-Stake consensus mechanism, enabling fast transaction finality and maintaining high network performance. It incorporates a decentralized cross-chain bridging infrastructure that supports compatibility with Ethereum, IBC-enabled chains, and non-EVM blockchains like Solana. Injective's core exchange module features an advanced on-chain order book and matching engine for spot, perpetual, futures, and options markets. It aims to reduce Miner-Extractable Value (MEV) through frequent batch auctions and strives to offer zero gas fees for users. Smart contracts are powered by CosmWasm, facilitating seamless multi-chain transactions and enabling complex DeFi applications.

Injective seeks to serve as a foundation for diverse DeFi applications, offering essential infrastructure like an on-chain order book for building decentralized exchanges, prediction markets, and lending protocols. The INJ token is central to the platform, used for protocol governance, securing the network through staking, incentivizing developers, and capturing value from decentralized applications. Injective aims to facilitate a wide range of trading and yield-generating activities, supporting interoperability across multiple layer-one blockchains, including Cosmos and Ethereum, thereby broadening the scope of DeFi opportunities.

Injective was developed by Injective Labs, a research and development firm co-founded by Eric Chen, who brings expertise in blockchain protocols and traditional finance. Albert Chon, the CTO, is a Stanford graduate and former software engineer at Amazon, known for pioneering an Ethereum standard adopted by major projects. The Injective ecosystem aims to encompass over 100 projects and has grown to include more than 150,000 community members worldwide. The project has received backing from various investors, supporting its mission to expand decentralized finance infrastructure.

我們實時將 Injective 更新為 USD 貨幣。在 Coinbase 上獲取 Injective 的實時價格。

Injective 目前的市值為 US$5.068亿。高市值意味著資產受到市場的高度重視。

Injective 的歷史最高紀錄是 US$52.94。這是自從 Injective 推出以來的最高價格。

在過去 24 小時中，Injective 的交易量為 US$7593.015万。

與 Injective 市值相似的資產包括 Aptos, TrueUSD, Lighter 和許多其他資產。若要查看完整清單，請參閱我們的可比市值資產。

Injective 目前的循環供應量為 9997万。

Injective 在 Coinbase 的可交易資產中排名 86。受歡迎程度目前是根據相對市值。

目前，94% 的 Coinbase 使用者正在購買 Injective。換句話說，94% 的 Coinbase 客戶在過去 24 個小時以內透過交易增加了他們在 Injective 中的淨頭寸。